Eli Lilly EVP Amends Initial Beneficial Ownership Filing (Form 3/A)
ELI LILLY & Co
Subscribe to track LLY
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
š Eli Lilly & Co ($LLY) ā Form 3/A Initial Ownership Amendment
Insider: Adrienne S. Brown (EVP, President LLY Imm) Event Date: November 7, 2025 Reported Holdings: ā¢ Direct Common Stock: 7,045.237 shares ā¢ Restricted Stock Units: 3,669.091 units (vesting 2026ā2028)
Note: This amendment corrects the baseline share count to include shares unintentionally omitted from the original Form 3 filing.
Comprehensive Analysis
Executive Summary
On September 4, 2026, Eli Lilly & Co ($LLY) filed an amended initial statement of beneficial ownership (Form 3/A) on behalf of Adrienne S. Brown, Executive Vice President and President of Lilly Immunology. The filing amends the original Form 3 dated November 7, 2025 (originally filed November 14, 2025) to correct previously omitted direct stock holdings.
Holdings Breakdown
1. Non-Derivative Securities
- Common Stock (Direct): 7,045.237 shares
- Footnote Note: Corrects the number of shares previously reported to account for additional shares unintentionally omitted from the original Form 3 and subsequent Form 4 filings.
2. Derivative Securities (Restricted Stock Units)
- 391 RSUs: Vesting February 16, 2026
- 2,530 RSUs: Vesting November 1, 2026
- 394 RSUs: Vesting February 16, 2027
- 354.091 RSUs: Vesting February 16, 2028
- Total RSUs: 3,669.091 underlying common shares
Trading Significance
- Significance Rating: Low
- Rationale: Form 3/A filings reflect administrative corrections to baseline initial holdings rather than open-market buying or selling activity. There is no direct cash outlay or disposal associated with this filing.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.